Enovis Corporation
NYSE:ENOVMedical - Devices
+$0.73 today
- Market cap
- $1.56B
- Beta
- 1.49
- P/E (TTM)
- -1.1
- EPS (TTM)
- -$20.02
Volume 0.88M
Average 0.99M
Fair Value & DCF
Compare our fair value with your own assumptions
Intrinsic Alpha selects a valuation method suited to the business. Use the calculator below to build an independent scenario with your preferred cash-flow basis.
Enovis Corporation
NYSE:ENOV
Intrinsic Alpha fair value
Locked
Current Price
$27.10
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Build your own valuation
Test an independent scenario and compare it with Intrinsic Alpha's estimate.
Sign in to use the DCF calculator
Free accounts get 5 valuations per week. Upgrade for more.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | +12.9% | +5.1% (4yr)6 analysts |
| Net Income | N/A | N/A | N/A | N/A6 analysts |
| EBIT | N/A | N/A | N/A | N/A6 analysts |
Analysis
Recent growth has been strongest in Revenue at +12.9% over three years. Forward estimates point to Revenue at +5.1% (4yr), giving you a quick check on whether expectations are accelerating or cooling.
Estimates & History
Historical data and analyst estimates. Solid bars are actuals; dashed-border bars are future estimates.
Competitor Valuations
Peer stocks ranked by intrinsic value status
| Company | Market Cap | Price | Valuation | P/E | 1Y Return |
|---|---|---|---|---|---|
ITT Inc. NYSE:ITT | $18.84B | $211.18 | Fairly Valued | 37.5 | +15.08% |
IDEX Corporation NYSE:IEX | $17.45B | $237.63 | Undervalued | 33.0 | +45.24% |
Watts Water Technologies, Inc. NYSE:WTS | $12.03B | $360.39 | Overvalued | 30.7 | +37.12% |
Donaldson Company, Inc. NYSE:DCI | $10.04B | $86.70 | Undervalued | 22.5 | +0.38% |
The Middleby Corporation NASDAQ:MIDD | $6.11B | $135.16 | Undervalued | -18.8 | +23.12% |
EnPro Industries, Inc. NYSE:NPO | $5.79B | $273.63 | Overvalued | 180.5 | +28.73% |
Franklin Electric Co., Inc. NASDAQ:FELE | $4.34B | $98.22 | Undervalued | 30.9 | +8.88% |
Kadant Inc. NYSE:KAI | $3.47B | $294.21 | Undervalued | 34.5 | +16.13% |
Enerpac Tool Group Corp. NYSE:EPAC | $2.02B | $39.37 | Overvalued | 22.3 | +1.41% |
The Gorman-Rupp Company NYSE:GRC | $1.84B | $69.66 | Overvalued | 39.2 | +58.13% |
Helios Technologies, Inc. NYSE:HLIO | $1.53B | $46.75 | Overvalued | 48.1 | -12.78% |
Graham Corporation NYSE:GHM | $979.18M | $83.42 | Overvalued | 97.6 | +41.34% |
Luxfer Holdings PLC NYSE:LXFR | $464.01M | $17.34 | Overvalued | 86.4 | +51.66% |
Omega Flex, Inc. NASDAQ:OFLX | $236.61M | $23.44 | Undervalued | 23.9 | -15.60% |
Hurco Companies, Inc. NASDAQ:HURC | $131.92M | $20.37 | Undervalued | -11.4 | +17.64% |
Continue the stock analysis
Jump to another research area for this company.